Judge Clears Path For Generic Dr. Reddy's Asthma Drug

Law360, New York (November 16, 2010, 2:15 PM EST) -- Indian drug maker Dr. Reddy's Laboratories Ltd. is in the clear to market a generic version of the asthma treatment Accolate after a federal judge ruled it did not infringe an AstraZeneca PLC patent.

On Monday, Judge Mary L. Cooper of the U.S. District Court for the District of New Jersey granted Dr. Reddy's motion for summary judgment of noninfringement, and she denied AstraZeneca's cross-motion for summary judgment on the issue of prosecution history estoppel.

In this case, it is undisputed that the accused generic compound...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.